The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: -0.50 (-0.72%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 69.50
Low: 69.00
Prev. Close: 69.50
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of ProtoCOL 3 Systems to Chinese SFDA

8 Feb 2013 07:00

RNS Number : 4207X
Scientific Digital Imaging Plc
08 February 2013
 



Scientific Digital Imaging plc

("SDI" or the "Company")

(AIM: SDI)

Chinese SFDA to Install 25 ProtoCOL 3 Systems from SDI

US $120,000 Order Shows Strength of SDI's Imaging Technology in Asian Market

 

Cambridge, UK: Scientific Digital Imaging (SDI), a leader in innovative digital imaging systems for life science, technology and astronomy applications, is pleased to announce that its Synbiosis Division has sold 25 ProtoCOL 3 automated colony counting and inhibition zone sizing systems, in one order worth US $120,000, to major government organisation, the Chinese State Food and Drug Administration (SFDA).

 

The SFDA (the Chinese equivalent of the EMEA and FDA) formulates policies and programmes for the administration of drugs, medical devices, health food and cosmetics. Microbiologists at the SFDA will be using the ProtoCOL 3 systems to help increase productivity of vaccine and antibiotic testing at their regional laboratories across China.

 

The order for 25 units of Synbiosis' ProtoCOL 3 systems came via Hua Yue Enterprise Holdings Ltd, one of SDI's expert Chinese distributors. This sale is the largest order for these colony counters in 2013 and closely follows another large installation of 27 ProtoCOL 3 systems in Asia in 2012. SDI has successfully sold into the Asian market for a number of years and the software for many of SDI's systems has been written in Chinese for over a decade, making it easier for Chinese life scientists to access and successfully use the technology.

 

Commenting on the news SDI's Chairman, Ken Ford, stated: "Selling the ProtoCOL 3 systems to the Chinese equivalent of the FDA is a coup. Our technology was in a rigorous tender process against systems from 10 other US, European and Chinese companies so to come out on top is a boost, not just for our Synbiosis Division, but also for other life science firms in Cambridge's innovation hub."

 

Mike Creedon, SDI's Chief Executive Officer, continued: "This purchase by such a prestigious government organisation is a great start to the year for SDI. With this being the second large order for ProtoCOL 3 systems in Asia in less than a year, it also shows that our strategy of moving into the untapped Asian market with our life science equipment portfolio is proving very fruitful."

-Ends-

 

 

FOR FURTHER INFORMATION

 

Scientific Digital Imaging plc 01223 727144

Ken Ford, Chairman

Mike Creedon, Chief Executive Officer

www.scientificdigitalimaging.com

 

finnCap 020 7220 0500

Ed Frisby/Rose Herbert - Corporate Finance

Simon Starr - Corporate Broking

 

 

Note to Editors

Scientific Digital Imaging Plc

 

Scientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. In addition under the Atik brand SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUBAVROOAURAR
Date   Source Headline
21st Sep 20227:00 amRNSAGM Trading Update
24th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM
1st Aug 20227:00 amRNSAcquisition of LTE Scientific Limited
28th Jul 20227:00 amRNSBoard Appointment
21st Jul 20227:00 amRNSFinal Results
19th Jul 20222:20 pmRNSNotice of Results and Investor Presentation
30th Jun 20227:00 amRNSBoard Changes
6th May 20229:08 amRNSSecond Price Monitoring Extn
6th May 20227:00 amRNSTrading Update
26th Apr 20225:20 pmRNSChange of Website
28th Mar 20227:00 amRNSAcquisition of Safelab Systems Limited and TVR
18th Mar 20221:10 pmRNSExercise of Share Options and Total Voting Rights
14th Jan 20222:40 pmRNSResult of Secondary Placing
14th Jan 20221:30 pmRNSSecondary Placing, Exercise of Options & TVR
11th Jan 20227:00 amRNSBoard Change
7th Jan 20227:00 amRNSAcquisition of SVS and Atik Order
17th Dec 202112:10 pmRNSExercise of Share Options and Total Voting Rights
7th Dec 20217:00 amRNSInterim Results
12th Nov 20217:00 amRNSInvestor Presentation
4th Nov 20217:00 amRNSTrading Update and Notice of Results
15th Oct 202112:45 pmRNSHolding(s) in Company
1st Oct 20215:15 pmRNSTotal Voting Rights
1st Oct 202112:45 pmRNSLong Term Incentive Plan Awards
23rd Sep 202111:15 amRNSHolding(s) in Company
22nd Sep 20214:28 pmRNSResult of AGM
22nd Sep 20217:00 amRNSAGM Trading Update
3rd Sep 202111:30 amRNSExercise of Options, Director Shareholding and TVR
26th Aug 20219:45 amRNSHolding(s) in Company
23rd Aug 202111:45 amRNSPosting of Annual Report and Notice of AGM
20th Jul 20217:00 amRNSFinal Results
1st Jul 20214:30 pmRNSTotal Voting Rights
23rd Jun 20217:00 amRNSInvestor Presentation
10th Jun 202112:45 pmRNSHolding(s) in Company
27th May 20215:30 pmRNSExercise of Options, Director Shareholding & TVR
26th May 20216:15 pmRNSDirector Dealing
26th May 20217:00 amRNSTrading Update
12th May 20217:00 amRNSNotice of Results
26th Apr 20219:25 amRNSExercise of Options and Total Voting Rights
14th Apr 20214:26 pmRNSExercise of Options and Total Voting Rights
14th Apr 20214:16 pmRNSDirector Dealing
6th Apr 20213:50 pmRNSExercise of Options and Total Voting Rights
1st Apr 20213:13 pmRNSDirector Dealing
3rd Mar 20212:19 pmRNSHolding(s) in Company
2nd Mar 20214:53 pmRNSHolding(s) in Company
22nd Feb 20214:41 pmRNSHolding(s) in Company
10th Feb 20214:05 pmRNSHolding(s) in Company
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
10th Feb 20219:03 amRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSTrading Update
1st Feb 20217:00 amRNSAcquisition of Uniform Engineering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.